Ask question
Ask question
×
Drotaverine



Drotaverine

40 mg tablets

INN: Drotaverine

Registration number: LS-002099

Pharmacotherapeutic group: Antispasmodic agent

Indications for use:

Smooth muscle spasm associated with diseases of the biliary system: cholecystolithiasis, cholangitis, pericholecystitis, inflammation of the duodenal papilla.

Smooth muscle spasm associated with diseases of the urinary tract: nephrolithiasis, ureterolithiasis, pyelitis, cystitis, bladder spasm. As part of the adjuvant therapy: spasm of smooth muscles of the gastrointestinal tract: gastric ulcer and duodenal ulcers, gastritis, gastric cardia and pylorus spasm, enteritis, colitis, spastic colitis with constipation and irritable bowel syndrome with flatulence; tension headache; dysmenorrhea.

When conducting certain tool-aided tests, including cholecystography.

Presentation:

40 mg tablets.

10 tablets in blister packaging.

1, 2 or 5 blister packs with instructions for use in carton packaging.



Leave a comment